Sanofi India Ltd - 500674 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Outcome of Postal Ballot along with Scrutinizer''s Report14-02-2024
14-02-2024
Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has approved issue of duplicate share certificates requests in lieu of the original share certificates reported lost/misplaced.13-02-2024
Sanofi India Ltd - 500674 - Announcement Under Regulation 30 (LODR)
Announcement under Regulation 30 (LODR)08-02-2024
Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company will hold an investor / analysts call for update on Financial Results for the quarter and year ended 31st December 2023 on 26th February 2024 at 11:30 a.m.08-02-2024
Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulation 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s).08-02-2024
Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform that the Company has approved issue of duplicate share certificates requests in lieu of the original share certificates reported lost/misplaced.02-02-2024
Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s).31-01-2024
Sanofi India Ltd - 500674 - Board Meeting Intimation for Consideration And Approval Of Audited Financial Statements (Standalone & Consolidated) For The Quarter And Financial Year Ended 31St December 2023 And For Recommendation Of Dividend, If Any.
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/02/2024 ,inter alia, to consider and approve the Audited Financial Statements (Standalone & Consolidated) for the Quarter and Financial Year ended 31st December 2023 and recommend of dividend, if any, for the Financial Year ended 31st December 2023.24-01-2024
Sanofi India Ltd - 500674 - Compliances - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) 2015 For The Year Ended 31St December 2023.
Pursuant to Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith Certificate of M/s. Makarand M. Joshi & Co., Company Secretaries for the year ended 31st December 2023.24-01-2024
Sanofi to buy Inhibrx for $2.2 billion in rare disease push
The acquisition is the latest in a string of small- and mid-sized deals as Sanofi looks to double down on innovative medicines and reduce its reliance on the blockbuster asthma medicine Dupixent.23-01-2024